Fireweed Announces Management Change and Adds Strength to its Leadership
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF; […]
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series
BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) — 10 Barrel Brewing Co. (“10 Barrel Brewing Co.” or “10 Barrel”), a […]
Uniti Group Inc. Reports First Quarter 2024 Results
Announced Merger with Windstream Creates Premier Insurgent Fiber Provider Updates 2024 Outlook Net Income of $41.3 Million for the First […]
TransAlta Reports First Quarter 2024 Results
CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) — TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported […]
Shenandoah Telecommunications Company Reports First Quarter 2024 Results
EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter […]
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) — Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal […]
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in […]
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider
Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support […]
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full […]
Galera Adopts Limited Duration Stockholder Rights Agreement
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a […]
